Basics of Surgery - 2nd Year MBBS Notes
Sources: Bailey & Love's Surgery 28th Ed | Sabiston Textbook of Surgery | Schwartz's Surgery 11th Ed | Scott-Brown's Otorhinolaryngology | Mulholland & Greenfield's Surgery
UNIT 1: WOUND HEALING
Definition
A wound is a disruption of the normal continuity of body structures. Wound healing is the complex biological process of restoring tissue integrity.
Types of Wound Healing
| Type | Also Called | When It Occurs |
|---|
| Primary intention | First intention | Clean wound, edges approximated within 12-24h (surgical incision, clean laceration) |
| Secondary intention | Second intention | Large/infected wound left open; heals by granulation tissue from base upward |
| Tertiary intention | Delayed primary closure | Wound left open initially (contaminated), then closed after 4-5 days once clean |
"Healing by first intention is characterized by closure of a wound within 12-24 hours of its formation. These wounds are clean and well perfused... Wound edges are approximated using sutures, skin glue, steri-strips or other mechanical devices." - Scott-Brown's Otorhinolaryngology
Four Phases of Wound Healing (KEY EXAM TOPIC)
Phase 1: Haemostasis (Immediate - minutes)
- Vascular spasm (immediate response)
- Platelet plug formation: platelets adhere to exposed collagen via von Willebrand factor → platelet activation → aggregation (primary haemostasis)
- Coagulation cascade activated → fibrin clot formation (secondary haemostasis)
- Clot acts as scaffold for subsequent healing
Phase 2: Inflammation (Days 1-4)
- Vasodilation and increased vascular permeability
- Neutrophils arrive first (day 1-2): phagocytose bacteria and debris
- Macrophages arrive day 2-3: debridement + release of growth factors (PDGF, TGF-β, VEGF) - the "master cells" of wound healing
- Signs: rubor (redness), calor (heat), dolor (pain), tumour (swelling), functio laesa (loss of function) - Celsus's pentad
- Lymphocytes arrive later - coordinate immune response
Phase 3: Proliferation (Days 4-21)
- Fibroblasts migrate in (attracted by macrophage-derived growth factors) and synthesise collagen (initially Type III - immature)
- Angiogenesis (new blood vessel formation) - driven by VEGF; gives granulation tissue its red granular appearance
- Epithelialisation - keratinocytes migrate across wound surface
- Wound contraction - myofibroblasts (fibroblasts with smooth muscle features) contract wound edges; major in secondary healing
Phase 4: Remodelling / Maturation (Day 21 - 2 years)
- Type III collagen replaced by stronger Type I collagen
- Collagen fibres reorganise along tension lines
- Vascularity decreases (scar becomes pale)
- Maximum tensile strength: ~80% of original skin (never reaches 100%)
- Scar matures over 12-24 months
Wound Strength Timeline
| Time | Tensile Strength |
|---|
| Day 0-3 | Nil (fibrin clot only) |
| Week 1-2 | ~5-10% |
| 3 weeks | ~20% |
| 6 weeks | ~50% |
| 3-6 months | ~80% (maximum) |
Factors Affecting Wound Healing
Local factors:
- Infection (most important local factor)
- Blood supply (ischaemia delays healing)
- Foreign body / dead tissue (slows healing)
- Haematoma / seroma (acts as culture medium)
- Wound closure tension
- Radiation damage
Systemic factors:
- Nutrition: Protein deficiency impairs collagen synthesis; Vitamin C needed for hydroxylation of proline/lysine in collagen; Zinc cofactor for collagen synthesis
- Diabetes mellitus (poor perfusion, neuropathy, impaired neutrophil function)
- Steroids / immunosuppressives (inhibit inflammation and collagen synthesis)
- Anaemia, hypoxia
- Age (decreased healing in elderly)
- Jaundice, uraemia
- Malignancy
Abnormal Wound Healing
| Condition | Description |
|---|
| Hypertrophic scar | Raised scar, stays within wound boundaries; regresses over time; treat with silicone, compression, steroids |
| Keloid | Grows beyond wound boundaries; does NOT regress; more common in darker skin, presternal/deltoid/earlobe; treat with excision + adjuvant radiotherapy (high recurrence) |
| Wound dehiscence | Reopening of wound; risk factors: infection, poor nutrition, obesity, steroids |
| Incisional hernia | Late complication of wound; abdominal wall defect under intact skin |
| Chronic wound | Fails to progress through normal healing phases; e.g., venous ulcer, diabetic foot ulcer, pressure sore |
UNIT 2: SHOCK
Definition
"Shock is a systemic state of low tissue perfusion that is inadequate for normal cellular respiration." - Bailey & Love's Surgery, p. 634
Pathophysiology at Cellular Level
- Reduced O₂ delivery → cells switch from aerobic → anaerobic metabolism
- Anaerobic metabolism produces lactic acid → systemic metabolic acidosis
- Na⁺/K⁺ pump failure → lysosomal enzyme release → cell lysis
- Potassium released → hyperkalaemia
- Microvascular injury → capillary leak → tissue oedema → worsens hypoxia
Systemic Compensatory Responses
| System | Response |
|---|
| Cardiovascular | Baroreceptor activation → ↑sympathetic tone → tachycardia + vasoconstriction |
| Respiratory | ↑ Respiratory rate → compensatory respiratory alkalosis |
| Renal | ↓ GFR → ↓ urine output; RAAS activated → Na + water retention, further vasoconstriction |
| Endocrine | ADH release → water retention; cortisol + glucagon → hyperglycaemia |
Classification of Shock (4 Types - CHOD)
1. Hypovolaemic Shock (most common surgical type)
- Loss of circulating volume: haemorrhage, burns, GI losses, third-space losses
- Haemorrhagic shock classes (ATLS):
| Class | Blood Loss | HR | BP | RR | Urine Output | Consciousness |
|---|
| I | <750 mL (<15%) | <100 | Normal | 14-20 | >30 mL/h | Normal |
| II | 750-1500 mL (15-30%) | 100-120 | Normal | 20-30 | 20-30 mL/h | Anxious |
| III | 1500-2000 mL (30-40%) | 120-140 | Decreased | 30-40 | 5-15 mL/h | Confused |
| IV | >2000 mL (>40%) | >140 | Very low | >35 | Negligible | Lethargic/unconscious |
2. Cardiogenic Shock
- Primary pump failure: MI (most common), arrhythmia, valvular disease, myocarditis, blunt cardiac injury
- Features: low CO, raised JVP, pulmonary oedema
- Treatment: Inotropes (dobutamine), treat cause
3. Obstructive Shock
- Mechanical obstruction to cardiac filling/output
- Causes: Cardiac tamponade, Tension pneumothorax, massive PE, air embolus
- Each causes reduced ventricular filling → low CO
- Treatment: Remove obstruction immediately (needle decompression for tension pneumothorax; pericardiocentesis for tamponade)
4. Distributive Shock
- Maldistribution of blood flow - peripheral vasodilation with low SVR
- Subtypes:
- Septic shock (most common distributive): endotoxin → cytokine storm → vasodilation + capillary leak + myocardial depression
- Anaphylactic shock: histamine-mediated vasodilation; treat with IM adrenaline 0.5 mg
- Neurogenic shock: loss of sympathetic tone (high spinal cord injury)
Septic shock: Warm peripheries early (high CO, low SVR) → Cold, clammy late (myocardial depression + hypovolaemia)
Summary Table: Cardiovascular Features
| Type | HR | BP | CO | SVR | JVP |
|---|
| Hypovolaemic | ↑ | ↓ | ↓ | ↑ | ↓ |
| Cardiogenic | ↑ | ↓ | ↓ | ↑ | ↑ |
| Obstructive | ↑ | ↓ | ↓ | ↑ | ↑ |
| Distributive (septic) | ↑ | ↓ | ↑ (early) | ↓ | ↓ |
Management Principles (Surgical Shock)
- Airway + O₂ (100% via non-rebreather mask)
- 2 large-bore IV cannulae (antecubital fossa, 14-16G)
- Bloods: FBC, U&E, LFT, coagulation, G&S / crossmatch, blood cultures (sepsis), lactate
- IV fluid resuscitation: crystalloid bolus (500 mL Hartmann's) - reassess after each bolus
- Urinary catheter - monitor urine output (target >0.5 mL/kg/h)
- Identify and treat the cause
- Blood products if haemorrhagic shock (1:1:1 ratio of PRBC : FFP : platelets in massive haemorrhage)
- Vasopressors (noradrenaline) if distributive shock unresponsive to fluids
UNIT 3: FLUID THERAPY & ELECTROLYTES
Body Fluid Compartments
| Compartment | % Body Weight | Volume (70 kg adult) |
|---|
| Total Body Water (TBW) | 60% | ~42 L |
| Intracellular fluid (ICF) | 40% | ~28 L |
| Extracellular fluid (ECF) | 20% | ~14 L |
| - Interstitial | 15% | ~10.5 L |
| - Intravascular (plasma) | 5% | ~3.5 L |
Maintenance Fluid Requirements (Adults)
- Water: 25-30 mL/kg/day (~2000 mL/day)
- Sodium: 1 mmol/kg/day (~70 mmol/day)
- Potassium: 1 mmol/kg/day (~70 mmol/day)
- Glucose: ~50-100g/day (prevents protein catabolism)
Standard maintenance regime: 1 L normal saline (0.9% NaCl) + 20 mmol KCl over 8h; followed by 1 L 5% dextrose + 20 mmol KCl over 8h; repeat cycle
Types of IV Fluids
| Fluid | Contents | Osmolality | Distribution | Use |
|---|
| 0.9% NaCl (Normal saline) | Na⁺ 154, Cl⁻ 154 mmol/L | 308 mOsm/L | ECF only | Resuscitation, hyponatraemia |
| Hartmann's / Ringer's lactate | Na 131, K 5, Ca 2, Cl 111, lactate 29 mmol/L | 278 mOsm/L | ECF only | Preferred resuscitation fluid (more physiological) |
| 5% Dextrose | 50g/L glucose | 278 mOsm/L | Distributes to all compartments | Maintenance, hypoglycaemia |
| Colloids (e.g., Gelatin) | Large molecules | - | Stays intravascular | Temporary volume expansion |
| Blood (PRBC) | - | - | Intravascular | Haemorrhage, severe anaemia |
Electrolyte Disturbances (Surgical Context)
Hyponatraemia (Na⁺ <135 mmol/L):
- Causes: excess hypotonic fluids, SIADH (post-op), GI losses
- Symptoms: confusion, seizures (if severe)
- Treat: fluid restriction; slow correction (max 10 mmol/24h to avoid central pontine myelinolysis)
Hypokalaemia (K⁺ <3.5 mmol/L):
- Causes: vomiting/NG drainage (with alkalosis), diuretics, diarrhoea
- Risks: cardiac arrhythmias, ileus
- Treat: IV KCl (max 20 mmol/h via central line); oral KCl supplements
Hyperkalaemia (K⁺ >5.5 mmol/L):
- Causes: renal failure, cell lysis, Addison's, massive transfusion
- Risks: cardiac arrest (sine-wave ECG pattern)
- Emergency treatment: IV calcium gluconate (membrane stabilisation) → insulin + dextrose → salbutamol → dialysis
UNIT 4: SURGICAL INFECTIONS
Classification of Wounds (Surgical)
| Class | Description | Infection Risk |
|---|
| Clean | Elective, no hollow organ entered (e.g., thyroidectomy, hernia repair) | 1-2% |
| Clean-contaminated | Hollow organ entered under controlled conditions (e.g., cholecystectomy, colonic resection with bowel prep) | 3-5% |
| Contaminated | Acute inflammation without pus; major breach of asepsis (e.g., fresh GI spillage, traumatic wound <4h) | 10-15% |
| Dirty/Infected | Established infection, faecal soiling, perforated viscus (e.g., perforated appendix, faecal peritonitis) | >30% |
Surgical Site Infection (SSI)
Definition (CDC): Infection occurring within 30 days of operation (or 1 year if implant placed) at the operative site.
Classification:
- Superficial incisional SSI: skin and subcutaneous tissue
- Deep incisional SSI: deep soft tissue (fascia, muscle)
- Organ/space SSI: any part of the anatomy opened during surgery (e.g., anastomotic leak, intraabdominal abscess)
Risk factors:
- Patient factors: diabetes, obesity (BMI >35), smoking, malnutrition, immunosuppression, ASA grade
- Operative factors: duration >2 hours, dirty/contaminated wound, inadequate prophylaxis, haematoma, dead space
Prevention:
- Antibiotic prophylaxis: single dose IV antibiotics 30-60 min before incision (e.g., co-amoxiclav or cefazolin); NOT extended beyond 24h
- Hair removal: clippers (not razors) on day of surgery
- Skin preparation: chlorhexidine-alcohol > povidone iodine
- Maintain normothermia and normoglycaemia intra-operatively
- Good surgical technique (minimise dead space, avoid haematoma)
Common Surgical Infections
Cellulitis: Spreading infection of dermis/subcutaneous tissue; Strep pyogenes / Staph aureus. Treatment: IV amoxicillin/clavulanate or flucloxacillin
Abscess: Localised collection of pus. Principle: "ubi pus, ibi evacua" (where there is pus, drain it). Treat by incision and drainage (I&D); antibiotics alone insufficient
Necrotising fasciitis:
- Rapidly spreading infection of fascia and subcutaneous fat; surgical emergency
- Type I: polymicrobial (Fournier's gangrene)
- Type II: monomicrobial (Group A Strep)
- Features: severe pain out of proportion to appearance, dusky skin, crepitus (gas-forming organisms), systemic toxicity
- Treatment: URGENT surgical debridement (often multiple washouts) + broad-spectrum antibiotics + ICU
Gas gangrene (Clostridial myonecrosis):
- Clostridium perfringens - gas in tissues, brown exudate, "dishwater" fluid
- Treatment: surgical debridement + penicillin G + hyperbaric oxygen
Tetanus
- Clostridium tetani - exotoxin (tetanospasmin) blocks inhibitory interneurons → spastic paralysis
- Features: trismus (lockjaw), opisthotonus, risus sardonicus
- Prophylaxis: wound toilet + tetanus toxoid (if >5 years since last booster); add tetanus immunoglobulin (TIG) if dirty wound + unimmunised
- Treatment: TIG + metronidazole + benzodiazepines (muscle relaxation) + ICU
UNIT 5: HAEMOSTASIS & BLOOD TRANSFUSION
Haemostasis - Overview
Primary haemostasis: Platelet plug (fast, within seconds)
- Vascular spasm
- Platelet adhesion: vWF bridges platelet GPIb receptor to exposed collagen
- Platelet activation: release of ADP, TXA₂ → more platelet recruitment
- Platelet aggregation: GPIIb/IIIa receptors bind fibrinogen
Secondary haemostasis (Coagulation cascade): Fibrin clot (minutes)
- Intrinsic pathway (XII → XI → IX → X): activated by contact with subendothelial collagen; measured by APTT
- Extrinsic pathway (VII + Tissue Factor → X): activated by tissue injury; measured by PT/INR
- Common pathway (X → Xa + Va → Prothrombin → Thrombin → Fibrinogen → Fibrin)
Fibrinolysis: Plasmin dissolves clot (tPA activates plasminogen → plasmin)
Tests of Coagulation
| Test | Pathway Tested | Normal Value |
|---|
| PT (Prothrombin Time) | Extrinsic + common | 11-13 seconds |
| INR | Standardised PT ratio | 0.8-1.2 |
| APTT | Intrinsic + common | 25-35 seconds |
| Thrombin Time (TT) | Final common | 10-15 seconds |
| Platelet count | Primary haemostasis | 150-400 × 10⁹/L |
| Bleeding time | Platelet function | 2-7 minutes |
Anticoagulants in Surgery
| Drug | Mechanism | Monitoring | Reversal |
|---|
| Heparin (UFH) | Activates antithrombin III (↑ AT-III activity) | APTT | Protamine sulphate |
| LMWH (enoxaparin, dalteparin) | Anti-Xa >> anti-IIa | Anti-Xa level | Partial reversal with protamine |
| Warfarin | Inhibits Vit K-dependent factors (II, VII, IX, X, Protein C&S) | INR | Vit K; FFP (emergency); 4-factor PCC (urgent) |
| DOACs (rivaroxaban, apixaban) | Direct factor Xa inhibition | No routine test | Andexanet alfa (specific) / PCC |
| Dabigatran | Direct thrombin (IIa) inhibitor | TT, ECT | Idarucizumab (specific) |
Blood Products & Transfusion
| Product | Contents | 1 Unit raises... | Indication |
|---|
| Packed Red Blood Cells (PRBC) | Red cells, Hb ~270 g/unit | Hb by ~1 g/dL | Anaemia, acute blood loss |
| Fresh Frozen Plasma (FFP) | All clotting factors | - | Coagulopathy, warfarin reversal |
| Platelets | Platelet concentrate | Platelets by ~30 × 10⁹/L | Thrombocytopenia, platelet dysfunction |
| Cryoprecipitate | Fibrinogen, vWF, Factor VIII, XIII | Fibrinogen by ~1 g/L | DIC, haemophilia A, vWD |
Transfusion trigger: Generally Hb <7-8 g/dL in stable patients (Hb <10 g/dL in cardiac patients or active ischaemia)
Complications of blood transfusion:
| Complication | Notes |
|---|
| Febrile non-haemolytic reaction | Most common; leukocyte antibodies; treat with paracetamol, slow transfusion |
| Acute haemolytic reaction | ABO incompatibility; STOP transfusion, IV fluids, check sample; life-threatening |
| Allergic/anaphylactic | Plasma protein antibodies; antihistamine/adrenaline |
| TRALI (Transfusion-Related Acute Lung Injury) | Non-cardiogenic pulmonary oedema within 6h; supportive |
| TACO (Transfusion-Associated Circulatory Overload) | Pulmonary oedema in fluid-sensitive patients; treat with diuretics |
| Infection (viral/bacterial) | Rare with modern screening |
| Massive transfusion complications | Hypocalcaemia (citrate chelates Ca²⁺), hypothermia, dilutional coagulopathy, hyperkalaemia |
UNIT 6: PRE-OPERATIVE & POST-OPERATIVE CARE
Pre-operative Assessment
History:
- Current illness + planned surgery
- Past medical/surgical history
- Medications (especially anticoagulants, antiplatelets, antihypertensives, steroids, insulin)
- Allergies
- Anaesthetic history (family history of malignant hyperthermia)
- Smoking, alcohol, substance use
- Last oral intake (fasting status: 6h for solids, 2h for clear fluids - "6-4-2 rule")
Examination: Cardiovascular, respiratory, airway (Mallampati classification)
Investigations:
| Test | Indication |
|---|
| FBC | All major surgery |
| U&E | Major surgery, renal disease, diuretics |
| LFT | Liver disease, jaundice, alcohol history |
| Coagulation (PT, APTT) | Bleeding disorder, anticoagulants, liver disease |
| Blood glucose/HbA1c | Diabetes |
| ECG | Age >40, cardiac history |
| CXR | Cardiac/respiratory disease, major surgery |
| Group & Save / Crossmatch | Expected blood loss |
| Echo, stress test | Significant cardiac history |
ASA Physical Status Classification:
| Grade | Description | Example |
|---|
| I | Healthy patient | Young fit adult |
| II | Mild systemic disease | Controlled DM, mild HTN |
| III | Severe systemic disease | Poorly controlled DM, COPD, stable angina |
| IV | Severe, constant threat to life | Recent MI, severe COPD, liver failure |
| V | Moribund, not expected to survive 24h | Ruptured AAA |
| VI | Brain-dead organ donor | - |
| E suffix | Emergency surgery | e.g., IIE, IIIE |
Consent: Informed, voluntary, patient must have capacity; must discuss benefits, risks (common + serious), alternatives including no treatment
Pre-operative Preparation
- Fasting: 6h solids, 2h clear fluids
- Stop anticoagulants appropriately (warfarin 5 days; DOACs 24-48h; aspirin continue for most surgery)
- Diabetic management: omit morning oral hypoglycaemics on day of surgery; start insulin sliding scale if prolonged fasting
- Prophylactic LMWH for DVT prevention (start evening before or post-op)
- TED stockings / intermittent pneumatic compression
- Antibiotic prophylaxis: single dose 30-60 min before incision
- Bowel prep (selected colorectal cases only)
- Consent and marking the site (especially for laterality)
Post-operative Monitoring
- Observations every 15-30 min initially: HR, BP, RR, SpO₂, temperature, GCS
- Urine output: target >0.5 mL/kg/h (30 mL/h in 70 kg adult)
- NEWS2 score (National Early Warning Score): triggered escalation for deteriorating patients
Post-operative Complications - Timeline
| Time | Complication |
|---|
| Immediate (0-24h) | Primary haemorrhage, airway obstruction, anaphylaxis, MI, arrhythmia |
| Early (1-3 days) | Reactionary haemorrhage (vasodilation), atelectasis, aspiration pneumonia, UTI, paralytic ileus, hypotension |
| Delayed (>3 days) | DVT/PE, secondary haemorrhage (infection eroding vessel), wound infection, anastomotic leak (day 5-7), SIADH, chest infection |
| Late (weeks-months) | Incisional hernia, adhesional obstruction, keloid, port-site hernia |
Common post-op complications by system:
Respiratory:
- Atelectasis (most common, days 1-2): microcollapses → fever, ↓O₂; treat with physiotherapy, incentive spirometry
- Pneumonia: cough, fever, consolidation; treat with antibiotics
- PE (day 5-10 peak): pleuritic chest pain, haemoptysis, tachycardia; CTPA to confirm; treat with anticoagulation
Cardiovascular:
- DVT: calf pain, swelling; duplex USS; treat with LMWH then DOAC for 3 months
- MI: ECG + troponin; highest risk day 1-3 post-op
Wound:
- Haematoma: collection of blood; usually resolves; aspirate/drain if large
- Seroma: serous fluid collection; common post-mastectomy/hernia; aspirate if symptomatic
- Wound infection (SSI): days 4-7; erythema, pus, fever; open wound + antibiotics
Urinary:
- Retention: common post-pelvic surgery and in elderly men; catheterise
- UTI: very common; MSSU + antibiotics
UNIT 7: SURGICAL NUTRITION
Importance
Surgery is a catabolic state. Stress response (cortisol, glucagon, adrenaline) → protein breakdown, glucose intolerance, negative nitrogen balance. Malnutrition delays wound healing, impairs immunity, prolongs hospital stay.
Nutritional Assessment
- History: weight loss (>10% in 6 months = significant), reduced intake
- BMI: <18.5 kg/m² = underweight
- MUST score (Malnutrition Universal Screening Tool): BMI + weight loss + acute disease effect → low/medium/high risk
- Serum albumin (<35 g/L = hypoalbuminaemia; marker of chronic malnutrition)
- Serum prealbumin (half-life 2-3 days, better acute marker)
Nutritional Requirements (Surgical Patient)
- Calories: 25-30 kcal/kg/day (higher if sepsis/burns/major trauma: up to 35-40)
- Protein: 1-2 g/kg/day (nitrogen balance)
- Key micronutrients for healing: Vitamin C, Zinc, Vitamin A
Routes of Nutritional Support
| Route | Indication | Notes |
|---|
| Oral | First choice if gut functioning | Encourage early post-op eating |
| Enteral (NGT/NJT) | Gut functioning but unable to eat | "If the gut works, use it" |
| Total Parenteral Nutrition (TPN) | Non-functional gut: ileus, short bowel, high-output fistula, severe IBD | Via central venous catheter; expensive; high complication rate |
Advantages of enteral over parenteral:
- Maintains gut mucosal integrity (prevents bacterial translocation)
- Lower cost
- Lower infection risk (TPN associated with line infections, metabolic complications)
- Preserves gut immune function
TPN complications: Line sepsis, hyperglycaemia, electrolyte imbalance (especially hypophosphataemia = refeeding syndrome), hepatic steatosis, metabolic acidosis
Refeeding syndrome: Rapid reintroduction of carbohydrates in malnourished patients → intracellular shift of phosphate, potassium, magnesium → severe hypophosphataemia → cardiac arrhythmia, respiratory failure, death. Prevent: start feeds slowly, supplement phosphate/K/Mg
UNIT 8: SURGICAL ONCOLOGY BASICS
Tumour Classification
| Type | Origin | Features |
|---|
| Benign | Any tissue | Well-differentiated, encapsulated, no metastasis, local pressure effects |
| Malignant | Any tissue | Poorly differentiated, invasive, metastasises, anaplastic features |
| Carcinoma | Epithelium | Most common in adults |
| Sarcoma | Connective tissue / mesenchyme | Bone, muscle, fat, vessels |
| Lymphoma | Lymphoid tissue | |
| Teratoma | Germ cells | |
Staging (TNM System)
- T - Primary tumour (T0-T4)
- N - Regional lymph nodes (N0-N3)
- M - Distant metastasis (M0-M1)
Routes of Tumour Spread
- Direct / local invasion - into adjacent structures
- Lymphatic spread - most common route for carcinomas
- Haematogenous spread - common for sarcomas; via portal vein → liver; systemic veins → lungs
- Transcoelomic spread - across body cavities (peritoneum, pleura); e.g., gastric cancer → "Sister Mary Joseph nodule" (umbilical), Krukenberg tumour (ovary)
- Perineural spread - along nerve sheaths (e.g., prostate cancer)
- Implantation - port site metastasis after laparoscopy, surgical seeding
Tumour Markers (Surgical Context)
| Marker | Tumour |
|---|
| CEA | Colorectal cancer (monitoring recurrence) |
| CA 19-9 | Pancreatic cancer |
| CA 125 | Ovarian cancer |
| AFP | Hepatocellular carcinoma, testicular (non-seminoma) |
| PSA | Prostate cancer |
| β-hCG | Choriocarcinoma, testicular (seminoma + non-seminoma) |
QUICK REVISION TABLE - High Yield Points
| Topic | Key Fact |
|---|
| Wound healing phases | Haemostasis → Inflammation → Proliferation → Remodelling |
| "Master cell" of wound healing | Macrophage |
| Max tensile strength of healed wound | ~80% of original skin |
| Keloid vs hypertrophic scar | Keloid extends beyond wound borders; does not regress |
| Shock definition | Inadequate tissue perfusion for cellular respiration |
| Class III haemorrhagic shock | 30-40% blood loss; BP drops; confused patient |
| Most common cause of surgical shock | Hypovolaemia |
| Distributive shock features | Warm, vasodilated (early); high CO; low SVR |
| Surgical wound classes | Clean → Clean-contaminated → Contaminated → Dirty |
| Antibiotic prophylaxis timing | 30-60 min before incision; single dose |
| TPN complication to know | Refeeding syndrome (hypophosphataemia) |
| Enteral over parenteral advantage | Maintains gut mucosa, prevents bacterial translocation |
| Most common post-op complication | Atelectasis (day 1-2) |
| PE peak timing post-op | Day 5-10 |
| DVT prophylaxis | LMWH + TED stockings + early mobilisation |
| Malignant tumour spread (carcinoma) | Lymphatic most common |
| Von Willebrand factor role | Bridges platelet GPIb to subendothelial collagen |
Sources: Bailey and Love's Short Practice of Surgery 28th Ed | Sabiston Textbook of Surgery | Schwartz's Principles of Surgery 11th Ed | Scott-Brown's Otorhinolaryngology Head & Neck Surgery | Mulholland & Greenfield's Surgery 7th Ed